Inventor
OUATHEK OUERFELLI
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides17%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C07DHeterocyclic compounds8%
C07BGeneral methods of organic chemistry4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07HSugars4%
PatentTitleYear
12,570,755Anti-CD20 antibody and uses thereof202612,522,664Anti-CD20 antibody and uses thereof202612,018,008Crystalline forms of an androgen receptor modulator202411,673,961Anti-CD20 antibody and uses thereof202311,565,005Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy202311,413,354N-acetylgalactosamino dendron-clearing agent for dota-pretargeted radioimmunotherapy2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (5)· patent assignee history
2022–2026Based in US· patent location history
2024Patents assigned to ARAGON PHARMACEUTICALS INC (1)· patent assignee history
2024Patents assigned to SLOAN KETTERING INST CANCER RES (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 5 | 2022–2026 |
| ARAGON PHARMACEUTICALS INC | 1 | 2024 |
| SLOAN KETTERING INST CANCER RES | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |